Navigation Links
Velocity Pharmaceutical Development and Tigercat Pharma Inc. Announce Submission of IND Application for VPD-737
Date:8/19/2013

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2013 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.

Tigercat licensed worldwide rights to VPD-737 (Serlopitant), an NK-1 receptor antagonist, from Merck (Essex Chemie) in 2012.  Tigercat intends to develop VPD-737 through clinical proof of concept for the treatment of chronic pruritus, defined as itch lasting for more than 6 weeks. This condition results in more than one million doctor visits per year in the US. Chronic pruritus is associated with significant morbidity and can result in serious disruption of sleep and other activities of daily living.

"Preclinical studies and compelling clinical evidence about the use of NK-1 receptor antagonists led us to believe that treatment with VPD-737 may significantly and rapidly reduce pruritus associated with a variety of conditions" said David Collier, CEO of VPD. "We believe this drug has the potential to address a major underappreciated medical need."

Jean Tang M.D., Ph.D., Professor of Dermatology at Stanford University School of Medicine said "Chronic itch is a largely underserved indication with few effective treatments.  The existing drugs to treat chronic itch are at best only modestly effective and in addition, they are poorly tolerated. Thus we are very excited to see VPD-737 approaching clinical testing."

About Tigercat Pharma, Inc.
Tigercat Pharma, Inc., is a largely "virtual" company which was created to hold the ownership of the VPD-737 development program.  Tigercat is funded by Velocity Pharmaceutical Holdings, LLC, and Remeditex Ventures, LLC.  The VPD-737 development program is managed
'/>"/>

SOURCE Velocity Pharmaceutical Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmaceutical Cold Supply Chain and Green Logistics, a New Xtalks Life Sciences Webinar
2. Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results
3. Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte
4. GW Pharmaceuticals to Present at the 33rd Annual Canaccord Genuity Growth Conference
5. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
6. Flagship Biosciences Expands Digital Pathology with Pharmaceutical Biostatistics Services
7. India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
8. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
9. PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals
10. RXi Pharmaceuticals Announces Application for NASDAQ Capital Market Listing and Reverse Stock Split
11. China Pharmaceutical Industry Examined in New Kelly Scientific Publications Report Available at MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Yan, Distinguished Professor of Engineering at the University ... to solve problems in energy engineering, environmental sustainability ... on zeolites, porous rock with a well-defined, crystalline ... is so precisely decided that zeolites can separate ... of an angstrom (one-tenth of a nanometer), making ...
(Date:7/24/2014)... 24, 2014 Your cell phone ... modeling lithium-ion battery storage capacity. , New research ... theoretical model created at Lawrence Livermore National ... predicts how carbon components will perform as electrodes. ... the urgent need for higher-performance batteries. Several key ...
(Date:7/24/2014)... 24, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Sulphate basic information, including its definition, classification, ... This research covers the international market analysis, including ... analysis covering macroeconomic environment & economic situation analysis, ...
(Date:7/24/2014)... The first part of the session on “Best ... Studies” will cover comprehensive clinical support in early phase ... R&D costs and declining industry success in getting products ... collected in early Phase I/IIa study data to make ... development. , Next, the presenters will examine steps to ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2Getting More Life out of Lithium-ion Batteries 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... Jan. 29 CuraGen Corporation (Nasdaq: CRGN ), ... and calendar year of 2008 and provided milestone and ... three month period ended December 31, 2008, CuraGen utilized ... fourth quarter with $88 million of cash and investments. ...
... development and production, today announced the appointment of David Pyrce as its ... ... Los Angeles (PRWEB) January 29, 2009 -- Nexsun Corp, a leader in ... David Pyrce as its Chief Executive Officer and member of the Board ...
... (Nasdaq: SGMO ) today announced that the ... financial results on Wednesday, February 4, 2009, after the ... a conference call at 5:00 p.m. ET, which will ... During the conference call, the company will review the ...
Cached Biology Technology:CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 2CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 3CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 4CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 5CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009 6Nexsun Corp Names Industry Executive David Pyrce as Chief Executive Officer 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast 2Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast 3
(Date:7/25/2014)... consume the healthcare community and remain priority ... To address the worldwide crisis of obesity ... global leaders in diabetes, epidemiology and public ... and development of diverse intervention programs in ... This book on "Global Health Perspectives in ...
(Date:7/25/2014)... University of Adelaide has opened the way for the development ... , In Australia, annual barley production is second only to ... one of the most important diseases of barley. , Senior ... composition of special growths on the cell walls of barley ... leaf. , The research, by the ARC Centre of Excellence ...
(Date:7/25/2014)... pleiotropic factor characterized by the existence of numerous ... confer to the protein deeply different characteristics. NRG1 ... occurring during development and the different phases occurring ... axon regrowth, remyelination and target reinnervation, Researchers at ... the soluble NRG1 upregulation observed in Schwann cells ...
Breaking Biology News(10 mins):What constitutes an effective response to the global 'diabesity' tsunami? 2New hope for powdery mildew resistant barley 2
... contamination of drinking water does not have a ... of Wisconsin-Madison researchers on arsenic-tainted wells shows that ... the contamination. Naturally occurring arsenic in rocks ... where it poses no threat to groundwater, explains ...
... maps that allow conservationists to estimate the distribution of ... threatened species and those with specific habitats, according to ... Conservation Biology. Our study found that species ranges ... trend is particularly pronounced for birds that are threatened, ...
... dinosaur from the Early Jurassic has been discovered in ... Glacialisaurus hammeri and lived about 190 million years ago. ... is based on partial foot, leg and ankle bones ... Antarctica at an elevation of more than 13,000 feet. ...
Cached Biology News:Arsenic contamination lacks one-size-fits-all remedy 2Arsenic contamination lacks one-size-fits-all remedy 3Threatened birds may be rarer than geographic range maps suggest 2Threatened birds may be rarer than geographic range maps suggest 3Massive dinosaur discovered in Antarctica sheds light on life, distribution of sauropodomorphs 2
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
FRACTALKINE [Human] (Recombinant)...
... head automatically rises at the end of determination; triple-point calibration verification; refrigerator eliminates need for pumps and bath ... * ... ... ...
... The Luminex® 200 System with ... for developing single and multi-analyte assays ... contains the new, powerful user friendly ... user can design specific templates for ...
Biology Products: